Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorTahaoğlu, Ali Emre
dc.contributor.authorBalsak, Deniz
dc.contributor.authorErdoğdu, Emre
dc.contributor.authorBakır, Mehmet Sait
dc.contributor.authorAkşin, Şerif
dc.contributor.authorBala, Mesut
dc.contributor.authorToğrul, Cihan
dc.contributor.authorYalınkaya, Ahmet
dc.date.accessioned2019-05-13T09:03:30Z
dc.date.available2019-05-13T09:03:30Z
dc.date.issued2017
dc.identifier.citationTahaoglu, A. E., Balsak, D., Erdogdu, E., Bakır, M. S., Aksin, S., Bala, M., Toğrul, C., Yalınkaya, A. (2017). Bakri balloon placement effectively treats uterine atony and placenta previa. Biotechnology & Biotechnological Equipment, 31(4), 795-799.en_US
dc.identifier.issn1310-2818
dc.identifier.urihttps://doi.org/10.1080/13102818.2017.1298467
dc.identifier.urihttps://hdl.handle.net/11491/1484
dc.description.abstractThe aim of this study was to explore the success rates of Bakri balloon placement in patients with placenta previa and uterine atony. In addition, we compared bilateral internal iliac artery ligation (B-IIAL) and Bakri balloon placement in terms of their ability to inhibit haemorrhage in postpartum placenta previa patients. The hospital reports filed annually from 2010 to 2015 were reviewed. In total, 54 patients were evaluated: 42 patients with placenta previa and uterine atony were treated with Bakri balloons, and 12 placenta previa patients with postpartum haemorrhage underwent B-IIAL when medical treatment failed. The results showed that the success rates of Bakri balloon placement rate in placenta previa and uterine atony patients were 71.4% and 89.2%, respectively. The comparative analysis of placenta previa patients treated via Bakri balloon placement and B-IIAL showed that the requirements for packed red blood cell and fresh frozen plasma, pre- and post-partum haemoglobin levels, pre- and post-partum platelet counts, and hospitalization times differed significantly between the two groups (all p < 0.05). Bakri balloon tamponade could be considered an effective treatment for placenta previa and uterine atony. The technique is minimally invasive and can serve as a second-line treatment for patients with postpartum haemorrhage when medical procedures fail. © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.en_US
dc.language.isoeng
dc.publisherTaylor and Francis Ltd.en_US
dc.relation.isversionof10.1080/13102818.2017.1298467en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectBakri Balloonen_US
dc.subjectPlacenta Previaen_US
dc.subjectPostpartum Haemorrhageen_US
dc.subjectUterine Atonyen_US
dc.titleBakri balloon placement effectively treats uterine atony and placenta previaen_US
dc.typearticleen_US
dc.relation.journalBiotechnology and Biotechnological Equipmenten_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.identifier.volume31en_US
dc.identifier.issue4en_US
dc.identifier.startpage795en_US
dc.identifier.endpage799en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess